HRT and the FDA
As the FDA considers removing the warning label from hormone replacement therapy for symptoms of menopause, Jen Gunter, MD, explains the current science and when the risks outweigh the potential benefits.
Audio is streamed directly from the publisher (pscrb.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As the FDA considers removing the warning label from hormone replacement therapy for symptoms of menopause, Jen Gunter, MD, an OB/GYN and pain medicine physician and author of The Menopause Manifesto (Citadel Press, 2021) and Blood: The Science, Medicine, and Mythology of Menstruation (Citadel Press, 2024), explains the current science and when the risks outweigh the potential benefits.